Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) EBT Margin (2016 - 2025)

Lisata Therapeutics' EBT Margin history spans 11 years, with the latest figure at 2954.0% for Q4 2025.

  • For Q4 2025, EBT Margin fell 249300.0% year-over-year to 2954.0%; the TTM value through Dec 2025 reached 10322.35%, down 824405.0%, while the annual FY2025 figure was 10322.35%, 824405.0% down from the prior year.
  • EBT Margin reached 2954.0% in Q4 2025 per LSTA's latest filing, up from 6655.71% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 461.0% in Q4 2024 to a low of 6655.71% in Q2 2025.